C

Caladrius Biosciences Inc
LSE:0HS8

Watchlist Manager
Caladrius Biosciences Inc
LSE:0HS8
Watchlist
Price: 2.045 USD 1.74%
Market Cap: 39.6m USD

Wall Street
Price Targets

0HS8 Price Targets Summary
Caladrius Biosciences Inc

There are no price targets for 0HS8.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Caladrius Biosciences Inc Competitors:
Price Targets
HRTX
Heron Therapeutics Inc
208% Upside
ZBIO
Zenas Biopharma Inc
84% Upside
ABBV
Abbvie Inc
13% Upside
2171
CARsgen Therapeutics Holdings Ltd
44% Upside
ADCT
ADC Therapeutics SA
120% Upside
LTRN
Lantern Pharma Inc.
476% Upside
PRQR
ProQR Therapeutics NV
499% Upside
AMRN
Amarin Corporation PLC
18% Downside

Revenue
Forecast

Revenue Estimate
Caladrius Biosciences Inc

For the last 13 years the compound annual growth rate for Caladrius Biosciences Inc's revenue is -16%. The projected CAGR for the next 4 years is 65%.

-16%
Past Growth
65%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-93%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0HS8's stock price target?
Not Available

0HS8 doesn't have any price targets made by Wall Street professionals.

What is Caladrius Biosciences Inc's Revenue forecast?
Projected CAGR
65%

For the last 13 years the compound annual growth rate for Caladrius Biosciences Inc's revenue is -16%. The projected CAGR for the next 4 years is 65%.

Back to Top